<p>Cell cycle phases distribution in human glioblastoma (T98G) versus non cancer (HaCaT) cell lines after 12 and 48h temozolomide (TMZ) treatment was carried out using FACS calibur flow cytometer by DNA staining with propidium iode. TMZ treatment resulted in G2M phase arrest in both tested cell lines in a dose dependent manner.</p
<p>A) Real-time PCR analysis of P-gp expression levels in tumor cell lines. The TMZ-resistant HCT15 ...
Abstract Glioblastoma multiforme (GBM) is a devastat-ing disease with a dismal prognosis and a very ...
<p>Cells were treated with different concentrations of drugs as indicated for 48 h. Cell cycle statu...
<p>The percentage of cells in each phase of the cell cycle in cancer (T98G) versus non cancer (HaCaT...
<p>Modulation of the cell cycle (G1, S and G2) by TMZ treatment in A172 (A), LN229 (B), SF268 (C) an...
<p><b>A</b> LN18 glioma cells were TMZ treated for three days consecutively with 100 µM, 200 µM and ...
<p>(U138, T98G, C6) and HeLa cells at 3, 12, 24 and 48 h. HaCaT cell line was used as the reference....
<p>A) Relative growth rates (RGR) for tumor cell lines treated with TMZ. B) Relative growth rates fo...
<p>MGMT-deficient U87 cells or U87 cells engineered to over-express MGMT (U87+MGMT) were incubated w...
PubMed ID: 25835972Temozolomide (TMZ) is an alkylating drug used usually in glioma treatment by indu...
Glioblastoma is the most common and deadly type of brain cancer. A common drug used to treat gliobla...
Temozolomide (TMZ) is an alkylating drug used usually in glioma treatment by inducing the apoptosis ...
<p>Representative images of (A) U87-MG and U–SC, and (B) L0627 morphology after 48 h treatment with ...
<p>Normal (HaCaT) and tumor cells (HeLa, T98G and U118)were treated with different TMZ concentration...
<p>U118 cell line treated with 250 μM (empty circle) and 500 μM (gray circle) of TMZ at 3, 6, 9, 12,...
<p>A) Real-time PCR analysis of P-gp expression levels in tumor cell lines. The TMZ-resistant HCT15 ...
Abstract Glioblastoma multiforme (GBM) is a devastat-ing disease with a dismal prognosis and a very ...
<p>Cells were treated with different concentrations of drugs as indicated for 48 h. Cell cycle statu...
<p>The percentage of cells in each phase of the cell cycle in cancer (T98G) versus non cancer (HaCaT...
<p>Modulation of the cell cycle (G1, S and G2) by TMZ treatment in A172 (A), LN229 (B), SF268 (C) an...
<p><b>A</b> LN18 glioma cells were TMZ treated for three days consecutively with 100 µM, 200 µM and ...
<p>(U138, T98G, C6) and HeLa cells at 3, 12, 24 and 48 h. HaCaT cell line was used as the reference....
<p>A) Relative growth rates (RGR) for tumor cell lines treated with TMZ. B) Relative growth rates fo...
<p>MGMT-deficient U87 cells or U87 cells engineered to over-express MGMT (U87+MGMT) were incubated w...
PubMed ID: 25835972Temozolomide (TMZ) is an alkylating drug used usually in glioma treatment by indu...
Glioblastoma is the most common and deadly type of brain cancer. A common drug used to treat gliobla...
Temozolomide (TMZ) is an alkylating drug used usually in glioma treatment by inducing the apoptosis ...
<p>Representative images of (A) U87-MG and U–SC, and (B) L0627 morphology after 48 h treatment with ...
<p>Normal (HaCaT) and tumor cells (HeLa, T98G and U118)were treated with different TMZ concentration...
<p>U118 cell line treated with 250 μM (empty circle) and 500 μM (gray circle) of TMZ at 3, 6, 9, 12,...
<p>A) Real-time PCR analysis of P-gp expression levels in tumor cell lines. The TMZ-resistant HCT15 ...
Abstract Glioblastoma multiforme (GBM) is a devastat-ing disease with a dismal prognosis and a very ...
<p>Cells were treated with different concentrations of drugs as indicated for 48 h. Cell cycle statu...